Not applicableStudy completedNCT01343901
What this trial is testing
An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 210